mutation, Bodeker and colleagues recommend molecular genetic screening for
SDHB, SDHC, and SDHD in all head and neck paragangliomas.
19,20
The authors’
practice has been to offer patients genetic counseling and to collect and bank deiden-
tified blood and tumor DNA from patients with JP undergoing surgery for future
studies.
Fig. 2.
(
A
) Axial cut of a T1 MRI with contrast showing a left jugular foramen meningioma.
The tumor is designated by the white arrow. (
B
) Coronal cut of a T1 MRI with contrast
showing a left jugular foramen meningioma. The tumor is designated by the white arrow.
Fig. 3.
(
A
) Axial cut of a T1 MRI without contrast showing a right jugular foramen schwan-
noma. The tumor is designated by the white arrow. (
B
) Axial cut of a T1 MRI with contrast
showing enhancement of a right jugular foramen schwannoma. The tumor is designated by
the white arrow.
Wanna et al
175




